A potential host and virus targeting tool against COVID-19: Chemical characterization, antiviral, cytoprotective, antioxidant, respiratory smooth muscle relaxant effects of Paulownia tomentosa Steud.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 14 09 2022
revised: 23 11 2022
accepted: 02 12 2022
pubmed: 11 12 2022
medline: 19 1 2023
entrez: 10 12 2022
Statut: ppublish

Résumé

COronaVIrus Disease 2019 (COVID-19) is a newly emerging infectious disease that spread across the world, caused by the novel coronavirus Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Despite the advancements in science that led to the creation of the vaccine, there is still an urgent need for new antiviral drugs effective against SARS-CoV-2. This study aimed to investigate the antiviral effect of Paulownia tomentosa Steud extract against SARS-CoV-2 and to evaluate its antioxidant properties, including respiratory smooth muscle relaxant effects. Our results showed that P. tomentosa extract can inhibit viral replication by directly interacting with both the 3-chymotrypsin-like protease and spike protein. In addition, the phyto complex does not reduce lung epithelial cell viability and exerts a protective action in those cells damaged by tert-butyl hydroperoxide , a toxic agent able to alter cells' functions via increased oxidative stress. These data suggest the potential role of P. tomentosa extract in COVID-19 treatment, since this extract is able to act both as an antiviral and a cytoprotective agent in vitro.

Identifiants

pubmed: 36495668
pii: S0753-3322(22)01472-X
doi: 10.1016/j.biopha.2022.114083
pmc: PMC9721285
pii:
doi:

Substances chimiques

Antiviral Agents 0
Antioxidants 0
Plant Extracts 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114083

Informations de copyright

Copyright © 2022. Published by Elsevier Masson SAS.

Références

Biomolecules. 2020 Jun 04;10(6):
pubmed: 32512899
Front Genet. 2021 Jan 13;11:599970
pubmed: 33519902
Nat Prod Res. 2020 May;34(9):1326-1330
pubmed: 30663367
Clin Exp Immunol. 2018 Nov;194(2):253-258
pubmed: 30069878
Cytokine Growth Factor Rev. 2022 Feb;63:44-57
pubmed: 34836751
Brain Sci. 2021 Apr 02;11(4):
pubmed: 33918426
Bioorg Med Chem. 2013 Jun 1;21(11):3051-7
pubmed: 23623680
Front Chem. 2021 Oct 08;9:744376
pubmed: 34692642
Clin Microbiol Infect. 2021 Feb;27(2):289.e5-289.e7
pubmed: 33161149
Anal Biochem. 2006 Dec 1;359(1):94-105
pubmed: 17007806
J Biomol Struct Dyn. 2022 Jan;40(1):136-142
pubmed: 32811367
Future Microbiol. 2021 Sep;16:1105-1133
pubmed: 34468163
Int J Mol Sci. 2021 Aug 29;22(17):
pubmed: 34502276
Environ Sci Pollut Res Int. 2022 Oct;29(46):69341-69366
pubmed: 35986111
Br J Pharmacol. 2016 Sep;173(18):2726-38
pubmed: 27352269
J Clin Med. 2021 May 01;10(9):
pubmed: 34062770
Int J Surg. 2022 Aug;104:106818
pubmed: 35953020
Nutrients. 2019 Jan 10;11(1):
pubmed: 30634687
Biomolecules. 2018 Jul 28;8(3):
pubmed: 30060543
J Pharmacol Exp Ther. 1990 Mar;252(3):1318-23
pubmed: 2181112
J Med Chem. 2011 Jun 9;54(11):3885-94
pubmed: 21568323
Oxid Med Cell Longev. 2015;2015:318125
pubmed: 26180582
Diseases. 2017 Sep 05;5(3):
pubmed: 32962323
Curr Pharm Des. 2022;28(12):948-968
pubmed: 34218774
Cell Mol Neurobiol. 2022 Sep 14;:
pubmed: 36103031
Molecules. 2007 Jun 27;12(6):1210-9
pubmed: 17876290
World J Clin Cases. 2021 Apr 26;9(12):2763-2777
pubmed: 33969059
Struct Chem. 2022;33(5):1445-1465
pubmed: 35571865
Front Med (Lausanne). 2020 May 15;7:240
pubmed: 32574331
Molecules. 2022 Mar 22;27(7):
pubmed: 35408447
Neurol Sci. 2022 Jan;43(1):105-112
pubmed: 34668122
Environ Sci Pollut Res Int. 2022 Jul;29(31):46527-46550
pubmed: 35507224
Int J Mol Sci. 2021 Nov 23;22(23):
pubmed: 34884440
Oxid Med Cell Longev. 2020 Aug 12;2020:3173281
pubmed: 32855764
J Gen Virol. 2020 Sep;101(9):925-940
pubmed: 32568027
Chem Biodivers. 2022 Nov;19(11):e202200655
pubmed: 36125969
EClinicalMedicine. 2020 Apr 05;21:100331
pubmed: 32292899
Nutrients. 2022 Jan 21;14(3):
pubmed: 35276825
J Hypertens. 2004 Dec;22(12):2329-38
pubmed: 15614027
Int J Mol Sci. 2021 Nov 03;22(21):
pubmed: 34769350
Methods Mol Biol. 2010;627:147-55
pubmed: 20217619
Am J Physiol. 1999 Mar;276(3):L405-11
pubmed: 10070103
Food Chem. 2022 Mar 30;373(Pt B):131594
pubmed: 34838409
Antioxidants (Basel). 2021 Nov 10;10(11):
pubmed: 34829666
Am J Respir Cell Mol Biol. 2019 Aug;61(2):209-218
pubmed: 30742476
Oxid Med Cell Longev. 2018 Sep 17;2018:9089016
pubmed: 30310529
Nat Struct Mol Biol. 2020 Jun;27(6):529-532
pubmed: 32382072
Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166559
pubmed: 36174875
Med Chem. 2022 Aug 29;:
pubmed: 36043762
Front Cell Infect Microbiol. 2022 Aug 22;12:929430
pubmed: 36072227
Int J Mol Sci. 2019 Oct 08;20(19):
pubmed: 31597283
Cells. 2022 Apr 29;11(9):
pubmed: 35563805

Auteurs

Fabio Magurano (F)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy. Electronic address: fabio.magurano@iss.it.

Matteo Micucci (M)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza Rinascimento 6, 61029 Urbino, PU, Italy.

Domenico Nuzzo (D)

Istituto per la Ricerca e l'Innovazione Biomedica, CNR, via U. La Malfa 153, 90146 Palermo, Italy.

Melissa Baggieri (M)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Pasquale Picone (P)

Istituto per la Ricerca e l'Innovazione Biomedica, CNR, via U. La Malfa 153, 90146 Palermo, Italy.

Silvia Gioacchini (S)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Raoul Fioravanti (R)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Paola Bucci (P)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Maedeh Kojouri (M)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Michele Mari (M)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza Rinascimento 6, 61029 Urbino, PU, Italy.

Michele Retini (M)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Piazza Rinascimento 6, 61029 Urbino, PU, Italy.

Roberta Budriesi (R)

Department of Pharmacy and Biotechnology, Food Chemistry and Nutraceutical Lab, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.

Laura Beatrice Mattioli (LB)

Department of Pharmacy and Biotechnology, Food Chemistry and Nutraceutical Lab, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.

Ivan Corazza (I)

Department of Specialistic, Diagnostic and Experimental Medicine (DIMES), University of Bologna, S. Orsola-Malpighi University Hospital, Alma Mater Studiorum-University of Bologna, Bologna, Italy.

Valentina Di Liberto (V)

Department of Biomedicine, Neuroscience and Advanced Diagnostic, University of Palermo, 90128 Palermo, Italy.

Luigi Todaro (L)

Scuola di Scienze Agrarie, Forestali, Alimentari ed Ambientali, Università della Basilicata, Via dell'Ateneo Lucano 10, 85100 Potenza, Italy.

Roberto Giuseppetti (R)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Emilio D'Ugo (E)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Antonella Marchi (A)

Department of Infectious Diseases, Istituto Superiore di Sanità (ISS), Rome, Italy.

Marisabel Mecca (M)

Dipartimento di Scienze, Università della Basilicata, Via dell'Ateneo Lucano 10, 85100 Potenza, Italy.

Maurizio D'Auria (M)

Dipartimento di Scienze, Università della Basilicata, Via dell'Ateneo Lucano 10, 85100 Potenza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH